The Safety of Neoadjuvant Therapy with Polyethylene Glycol Liposome Adriamycin Combined with Docetaxel in Patients with Breast Cancer Complicated by Axillary Lymph Node Metastasis.

Li Wang,Ziru Guo, Shuo Zhang,Xiangmei Zhang,Xiaochong Zhang, Dengxiang Liu,Yunjiang Liu

Alternative therapies in health and medicine（2023）

引用 0|浏览6

暂无评分

摘要

The combination of polyethylene glycol liposome adriamycin and docetaxel in neoadjuvant chemotherapy in patients with early BC with axillary lymph node metastasis has certain cardiac safety. And in the human epidermal growth factor receptor-2 (HER-2) positive population, polyethylene glycol liposome adriamycin combined with docetaxel and trastuzumab also has certain cardiac safety.

查看译文

关键词

neoadjuvant therapy,axillary lymph node metastasis,breast cancer,lymph node metastasis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要